Skip to Main Content

Author Details

Adam R Brentnall
Queen Mary Universityof London
2010
78
27
PMIDPaper TitleJournal TitlePublished Year
38065518Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening.J Clin Epidemiol2024
38070530Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.Lancet Oncol2024
36635680Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester.BMC Womens Health2023
38017184An optimization framework to guide the choice of thresholds for risk-based cancer screening.NPJ Digit Med2023
38001476Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study.Breast Cancer Res2023
37650883Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.Genet Med2023
37061873Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.Genet Med2023
37059410Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.Am J Obstet Gynecol2023
37310244Evaluation of an AI Model to Assess Future Breast Cancer Risk.Radiology2023
37470832Safety and efficacy of artesunate treatment in severely injured patients with traumatic hemorrhage. The TOP-ART randomized clinical trial.Intensive Care Med2023
37005486Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).Br J Cancer2023
37095697Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri.Clin Trials2023
37095186Correction To: Quantifying the effects of risk-stratified breast cancer screening when delivered in real time as routine practice versus usual screening: the BC-Predict non-randomised controlled study (NCT04359420).Br J Cancer2023
36749434Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman.J Gen Intern Med2023
36831615Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK.Cancers (Basel)2023
34460111The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?Int J Cancer2022
35377465Comments on: "Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening".Int J Cancer2022
35426792Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.Genet Med2022
36434583Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statistics.BMC Health Serv Res2022
36223373Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission.PLoS One2022
33006394Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country.Int J Cancer2021
34697802Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.Cochrane Database Syst Rev2021
34072619Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?Cancers (Basel)2021
34209579The Relationship between Body Mass Index and Mammographic Density during a Premenopausal Weight Loss Intervention Study.Cancers (Basel)2021
33977903The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London.Int J Tuberc Lung Dis2021
32194845Integrin αvβ6-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus.Theranostics2020
32037401Errors in determination of net survival: cause-specific and relative survival settings.Br J Cancer2020
32064299External validation of a mammographic texture marker for breast cancer risk in a case-control study.J Med Imaging (Bellingham)2020
32708835Economic Evaluation of Population-Based <i>BRCA1/BRCA2</i> Mutation Testing across Multiple Countries and Health Systems.Cancers (Basel)2020
32226220Risk Models for Breast Cancer and Their Validation.Stat Sci2020
30412281Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.Int J Cancer2019
3140991216/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot.Br J Cancer2019
31259422The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy.J Pathol2019
31423486A Case-Control Study to Add Volumetric or Clinical Mammographic Density into the Tyrer-Cuzick Breast Cancer Risk Model.J Breast Imaging2019
30941651Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.Breast Cancer Res Treat2019
30746393Prediction of reader estimates of mammographic density using convolutional neural networks.J Med Imaging (Bellingham)2019
30452738Competing Risks for a Diagnosis of Invasive Breast Cancer-Reply.JAMA Oncol2019
27920368Use of the concordance index for predictors of censored survival data.Stat Methods Med Res2018
29884207Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds.Breast Cancer Res2018
30180877Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.Breast Cancer Res2018
30410058Reply to 'Comment on 'Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis".Br J Cancer2018
29402289A comparison of five methods of measuring mammographic density: a case-control study.Breast Cancer Res2018
29736009Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis.Br J Cancer2018
29370783Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK.BMC Public Health2018
29621362Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.JAMA Oncol2018
29346471Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.JAMA Oncol2018
29097444RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.Cancer Epidemiol Biomarkers Prev2018
27554303On standardized relative survival.Biometrics2017
34925706The impact of using weight estimated from mammographic images <i>vs</i> self-reported weight on breast cancer risk calculation.Proc SPIE Int Soc Opt Eng2017
28295486Estimating efficacy in trials with selective crossover.Stat Med2017
  • 1 - 50 of 78

Recommended Authors

Boston University Chobanian & Avedisian School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
University of Washington
Career Start Year 2005
Number of shared co-authors 4
Perelman School of Medicine, The University of Pennsylvania
Career Start Year 2005
Number of shared co-authors 1
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 0
Columbia University Irving Medical Center
Career Start Year 2004
Number of shared co-authors 0
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 0
Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
Career Start Year 2003
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center.
Career Start Year 2002
Number of shared co-authors 0
National Cancer Institute, National Institute of Health, 9 Medical Center Drive
Career Start Year 2002
Number of shared co-authors 1
Otto-Friedrich-University Bamberg
Career Start Year 2002
Number of shared co-authors 2
King Edward Memorial Hospital
Career Start Year 2002
Number of shared co-authors 0
The Usher Institute, The University of Edinburgh
Career Start Year 2001
Number of shared co-authors 2
UCL EGA Institute for Women's Health, University College London
Career Start Year 2000
Number of shared co-authors 2
University of Cambridge
Career Start Year 2000
Number of shared co-authors 1
Southern California Permanente Medical Group
Career Start Year 1998
Number of shared co-authors 0
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Career Start Year 1998
Number of shared co-authors 1
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Genetic Epidemiology, University of Cambridge
Career Start Year 1994
Number of shared co-authors 6
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
College of Nursing, University of South Florida
Career Start Year 1991
Number of shared co-authors 3
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 0
University of California irvine
Career Start Year 1988
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1987
Number of shared co-authors 1
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 4
MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 2
National Cancer Institute
Career Start Year 1977
Number of shared co-authors 1

Collaborators

University of Bologna
Co-authored papers 2
Institute of Cancer Research
Co-authored papers 2
David Geffen School of Medicine at University of California at Los Angeles
Co-authored papers 1
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 1
Xuzhou Central Hospital
Co-authored papers 1
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Co-authored papers 1
Royal London Hospital, Barts Health NHS Trust
Co-authored papers 1
University of Washington School of Medicine
Co-authored papers 1
American Medical Informatics Association, IEEE, Johns Hopkins University, Radiological Society of North America, University of California Los Angeles, University of California, Los Angeles
Co-authored papers 1
The Institute of Cancer Research
Co-authored papers 1
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 1
The William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
University of Liverpool, Molecular & Clinical Cancer Medicine
Co-authored papers 1
Co-authored papers 1
Cambridge University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1
Changhai Hospital
Co-authored papers 1